Correlation of yroid Profile and Lipid profile in Metabolic Syndrome patients

Farah Ahsan, Naeem Kureshi, Nita Garg

Abstract


Objective: The aim of our study is to assess thyroid function tests in patients with Metabolic Syndrome and to find a correlation between hypothyroidism and lipid profile in metabolic syndrome.

Study Design:A hospital based cross sectional study was conducted on patients attending the OPD of Medicine of GSVM Medical College, Kanpur (U.P) for a period of 10 months from January 2015 to October 2015. Atotal no. of 100 cases of Metabolic syndrome in the age group 30-60 yrs (According to IDF consensus 2006) were selected randomly for the study. Above 60 yrs and below 30 yrs were excluded from our study. Besides patients having any chronic illness such as TB, Carcinoma’s and patients on lipid lowering drugs were excluded from this study.

Methodology:All the 100 subjects were analyzed for Serum T3, Serum T4, Serum TSH and lipid profile. Samples were collected in fasting state and Sr. T3, T4 & TSH were estimated using ELISA competitive immunoassay method. Total Cholesterol & HDL Cholesterol were determined by enzymatic methods. LDL & VLDL were calculated and TG was estimated by an analytical method. Statistical analysis was done & results expressed in Mean±SD±SE.

Results:Out of 100 cases of Metabolic Syndrome, 20 were of Subclinical hypothyroidism, 7 had overt Hypothyroidism & 73 patients were Euthyroid. Among these patients Hypertriglyceridaemia, hypercholesterolaemia, raised LDL and low HDL was found in overt hypothyroidism, Subclinical hypothyroidism and to some extent in Euthyroid cases.


Keywords


Metabolic Syndrome, Subclinical hypothyroidism.

Full Text:

PDF

References


The IDF consensus: Worldwide definition of the metabolic syndrome. 2006.

Ross DS. Serum thyroid stimulating hormone measurement for assessment of thyroid function and disease. EndocrinolMetab Am. 2001;30:245-264.

US Preventive Services Task Force. Screening for thyroid disease: recommendation statement. Ann Intern Med. 2004; 140: 125-7.

Samuels MH. Subclinical thyroid disease in the elderly. Thyroid. 1998;8:803-13.

Meier C, Staub JJ, Roth CB et al. TSH controlled L- Thyroxine therapy reduces cholesterol levels and clinical symptoms in SCH: a double bling placebo controlled trial (Based Thyroid Study). J ClinEndocrinolMetab 2001; 86: 4860-6.

Luboshitzky R, AvivA et al. Risk factors for cardiovascular disease in women with SCH Thyroid. 2002; 12: 421-5.

Uzunlulu M, Yorulmaz F, Oguz A: Prevalence of SCH in patients with Metabolic Syndrome. Endocr J. 2007 Feb; 54(1): 71-6.

Sterling L. Diagnosis and treatment of thyroid disease: Clevel and CRC Press; 1975:pg 9-51.

Allain C.C; Poon LS: Chan CS; Richmond W; Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-5 (Pubmed).

Burstein M; Scholnick HR; Morfin R; Rapid method of isolation of lipoproteins form human serum by precipitation of polyanions. J Lipid Res 1970; 11:583-95 (Pubmed).

Fossati P; Prencipe L. Serum Triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28:2077-80 (Pubmed).

FreidwaldWi, Levy RI, Fredrickson DS. Estimation of the concentration of LDL cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502 (pubmed).

Lalit K Mehar, SuryanathKolapurakal et al. prevalence of hypothyroidism in patients with metabolic syndrome. Thyroid Research and Practice. 2013;18:499-502 (pubmed).

K. Alexander Iwen, Erich Schroder, Georg Brabant. Thyroid Hormones and the metabolic syndrome. Eu Thyroid J; 2013; 2: 83-92.

PrabinGyawali et al. Pattern of Thyroid Dysfunction in patients with metabolic syndrome and its relationship with components of metabolic syndrome. Diabetes Metab. J. 2015; 39:66-73.

Muhammad ShahzadSaleem et al. Relationship of thyroid stimulating hormone with metabolic syndrome in a sample of euthyroid Pakistani population. J Ayub Med Coll Abbottabad. 2011;23 (2):63-8.


Refbacks

  • There are currently no refbacks.